Low adherence is a problem that brings with it severe challenges and considerable cost to society. WHO ascertains that in developed countries, only 50 percent of patients with chronic diseases take their medication in the prescribed manner. In the United States, low adherence causes additional costs of USD 300 billion for the healthcare system annually. It is further responsible for 10 percent of hospital admissions and 23 percent of nursing home admissions. Globally, low adherence leads to one million patients’ death every year, and contributes to the threat of untreated diseases.
MedicPen’s products are intended to improve adherence and monitoring of medication. The following data shows that the problems are of equally great importance on the Swedish market, where low adherence and other forms of misuse and medication errors cause: